Alan L. Ho

1998–2025 年に発表

103
論文数
21,638
被引用数
55
h 指数
91
i10 指数

被引用数

Alan L. Ho の年別被引用数1976 年: 被引用 1 件1977 年: 被引用 1 件1992 年: 被引用 2 件1998 年: 被引用 2 件1999 年: 被引用 7 件2000 年: 被引用 36 件2001 年: 被引用 78 件2002 年: 被引用 113 件2003 年: 被引用 121 件2004 年: 被引用 101 件2005 年: 被引用 88 件2006 年: 被引用 69 件2007 年: 被引用 66 件2008 年: 被引用 59 件2009 年: 被引用 62 件2010 年: 被引用 51 件2011 年: 被引用 63 件2012 年: 被引用 56 件2013 年: 被引用 79 件2014 年: 被引用 87 件2015 年: 被引用 67 件2016 年: 被引用 76 件2017 年: 被引用 109 件2018 年: 被引用 138 件2019 年: 被引用 685 件2020 年: 被引用 977 件2021 年: 被引用 1,131 件2022 年: 被引用 1,018 件2023 年: 被引用 823 件2024 年: 被引用 1,199 件2025 年: 被引用 548 件2026 年: 被引用 19 件1978〜1991 年は被引用が無いため表示していません1993〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,319 件、この内訳の 30%中国: 引用元論文 1,515 件、この内訳の 13.7%ドイツ: 引用元論文 549 件、この内訳の 5%イタリア: 引用元論文 531 件、この内訳の 4.8%イギリス: 引用元論文 512 件、この内訳の 4.6%フランス: 引用元論文 412 件、この内訳の 3.7%カナダ: 引用元論文 385 件、この内訳の 3.5%日本: 引用元論文 377 件、この内訳の 3.4%スペイン: 引用元論文 321 件、この内訳の 2.9%オランダ: 引用元論文 291 件、この内訳の 2.6%オーストラリア: 引用元論文 244 件、この内訳の 2.2%スイス: 引用元論文 227 件、この内訳の 2%
0%30%その他 21.6%

分野

  • Medicine59.5%
  • Biochemistry, Genetics and Molecular Biology32.4%
  • Immunology and Microbiology3.8%
  • Neuroscience1.2%
  • Computer Science0.9%
  • Materials Science0.5%
  • その他1.7%

トピック

  • Cancer Immunotherapy and Biomarkers7.4%
  • Cancer Genomics and Diagnostics5.7%
  • Lung Cancer Treatments and Mutations3.1%
  • Immunotherapy and Immune Responses2.9%
  • RNA Interference and Gene Delivery2.8%
  • Ferroptosis and cancer prognosis2.4%
  • その他75.7%

共著者

全論文

検索で開く
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 被引用: 4,358

  2. OncoKB: A Precision Oncology Knowledge Base

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Omuro, Michael A. Postow, Dana E. Rathkopf, Alexander N. Shoushtari, Neerav Shukla, Martin H. Voss, Ederlinda Paraiso, Ahmet Zehir, Michael F. Berger, Barry S. Taylor, Leonard B. Saltz, Gregory J. Riely, Marc Ladanyi, David M. Hyman, José Baselga, Paul Sabbatini, David B. Solit, Nikolaus Schultz - JCO Precision Oncology 2017 被引用: 2,698

  3. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 被引用: 663

  4. HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis‐Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti - Cancer Discovery 2020 被引用: 289

  5. Immunogenic neoantigens derived from gene fusions stimulate T cell responses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard J. Wong, Neerav Shukla, Timothy A. Chan, Luc G.T. Morris - Nature Medicine 2019 被引用: 382

  6. Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 394

  7. Tipifarnib in Head and Neck Squamous Cell Carcinoma WithHRASMutations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 196

  8. Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 829

  9. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 被引用: 69

  10. Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

    著者: , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2018 被引用: 242

  11. In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse

    著者: , , , - Science 1999 被引用: 2,433

  12. Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 236

  13. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 被引用: 210

  14. Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Fetten, Anuja Kripani, David G. Pfister, Alan L. Ho, Amita Shukla‐Dave, John L. Humm, Simon N. Powell, Bob T. Li, Jorge S. Reis‐Filho, Luis A. Díaz, Richard J. Wong, Nadeem Riaz - Journal of Clinical Oncology 2024 被引用: 93

  15. American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gregory W. Randolph - Head & Neck 2022 被引用: 113

  16. SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

    著者: , , , , , , , , , , , , , , , , , - Cancer Discovery 2020 被引用: 109

  17. Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

    著者: , , , , , , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2022 被引用: 57

  18. Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric J. Moore, Joaquín J. García, Robert L. Foote, Alan L. Ho, Richard J. Wong, Timothy A. Chan, Simon N. Powell, Paul C. Boutros, John L. Humm, Amita Shukla‐Dave, David G. Pfister, Jorge S. Reis‐Filho, Nancy Y. Lee - JNCI Journal of the National Cancer Institute 2020 被引用: 160

  19. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valencia D. Thomas, Yaohui Xu, Beth McCullough, Mary A. Dwyer, Mai Q. Nguyen - Journal of the National Comprehensive Cancer Network 2021 被引用: 144

  20. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Agnès Viale, Wendy Winckler, Robert G. Maki, Levi A. Garraway, Alex Lash, Heidi Greulich, David E. Root, William R. Sellers, Gary K. Schwartz, Cristina R. Antonescu, Eric S. Lander, Harold Varmus, Marc Ladanyi, Chris Sander, Matthew Meyerson, Samuel Singer - Nature Genetics 2010 被引用: 726

  21. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review

    著者: , , , , - The Lancet Oncology 2010 被引用: 395

  22. Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 63

  23. Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Puja Venkat, Yaohui Xu, Siegrid S. Yu, Mehran Yusuf, Beth McCullough, Sara Espinosa - Journal of the National Comprehensive Cancer Network 2023 被引用: 117

  24. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian Ganly, Marc A. Cohen, Nancy Y. Lee - JAMA Network Open 2023 被引用: 47